[go: up one dir, main page]

MX391125B - PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD. - Google Patents

PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD.

Info

Publication number
MX391125B
MX391125B MX2017001192A MX2017001192A MX391125B MX 391125 B MX391125 B MX 391125B MX 2017001192 A MX2017001192 A MX 2017001192A MX 2017001192 A MX2017001192 A MX 2017001192A MX 391125 B MX391125 B MX 391125B
Authority
MX
Mexico
Prior art keywords
allopathies
treatment
pharmaceutical composition
oral administration
loratadine
Prior art date
Application number
MX2017001192A
Other languages
Spanish (es)
Other versions
MX2017001192A (en
Inventor
Flores Oliver Daniel Walls
Hernández Ramón Rodríguez
Original Assignee
Laboratorios Liomont S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Liomont S A De C V filed Critical Laboratorios Liomont S A De C V
Priority to MX2017001192A priority Critical patent/MX391125B/en
Priority to PCT/IB2018/050431 priority patent/WO2018138652A1/en
Publication of MX2017001192A publication Critical patent/MX2017001192A/en
Publication of MX391125B publication Critical patent/MX391125B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to the preparation of a pharmaceutical composition with an antihistamine agent, a descongesting agent, an antipyretic/analgesic agent and an antiviral agent in an oral administration for the treatment of allopathies related to the common cold.
MX2017001192A 2017-01-26 2017-01-26 PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD. MX391125B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2017001192A MX391125B (en) 2017-01-26 2017-01-26 PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD.
PCT/IB2018/050431 WO2018138652A1 (en) 2017-01-26 2018-01-24 Pharmaceutical composition of loratadine, phenylephrine, paracetamol and amantadine for oral administration, for the treatment of allopathies related to a common cold

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017001192A MX391125B (en) 2017-01-26 2017-01-26 PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD.

Publications (2)

Publication Number Publication Date
MX2017001192A MX2017001192A (en) 2018-07-25
MX391125B true MX391125B (en) 2025-03-21

Family

ID=62979398

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001192A MX391125B (en) 2017-01-26 2017-01-26 PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD.

Country Status (2)

Country Link
MX (1) MX391125B (en)
WO (1) WO2018138652A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052545A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
US8603523B2 (en) * 2005-06-17 2013-12-10 Aft Pharmaceuticals Limited Pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
MX2009001925A (en) * 2009-02-20 2010-08-20 Senosiain S A De C V Lab Oral pharmaceutical composition for use in respiratory diseases.
MX390488B (en) * 2015-06-17 2025-03-20 Laboratorios Liomont S A De C V PHARMACEUTICAL COMPOSITION OF AMANTADINE HYDROCHLORIDE-LORATADINE-PARACETAMOL FOR INTEGRATING A CAPSULE, FOR THE TREATMENT OF COLDS AMONG OTHER ALLOPATHIES.

Also Published As

Publication number Publication date
MX2017001192A (en) 2018-07-25
WO2018138652A1 (en) 2018-08-02

Similar Documents

Publication Publication Date Title
CL2015002733A1 (en) Pharmaceutical composition of s-ketamine hydrochloride.
SV2015005115A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
BR112016022465A2 (en) exendin-4-derived peptide glp-1 / glucagon double receptor agonists
MX2017009449A (en) JAK INHIBITOR.
PE20151301A1 (en) PHARMACEUTICAL FORMULATIONS RESISTANT TO IMPROPER HANDLING
CL2018000811A1 (en) Modified-release amino acid formulations administered orally.
CL2014002524A1 (en) Pharmaceutical composition comprising an active compound of formula 1, ccr3 antagonist, two diluents, a binder, a disintegrant and a lubricant; Dosage forms in capsule, tablet or tablet coated with film.
BR112017012406A2 (en) fixed ratio formulation of insulin glargine / lixisenatide
BR112017020307A2 (en) method to inhibit symptoms associated with alcohol intake, and, pharmaceutical composition
EP3435979C0 (en) COMPOSITION, IN PARTICULAR PREVENTIVE AND CURATIVE PHARMACEUTICAL COMPOSITION, BASED ON PEROXOMETALLATE
PE20150721A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING GEMIGLIPTIN AND METFORMIN, AND METHOD FOR THEIR PREPARATION
CL2016002354A1 (en) Compounds derived from benzamide with wnt inhibitory activity; intermediary compounds; pharmaceutical composition that includes them; use in the treatment of cancer and other diseases with inappropriate immune response.
MX2018005439A (en) OXADIAZOESPIRICAL COMPOUNDS FOR THE TREATMENT OF ABUSE AND ADDICTION TO DRUGS.
MX356789B (en) Prolonged-release diphenidol composition.
ECSP16086232A (en) (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
CL2016002656A1 (en) Process for obtaining and pharmaceutical composition of ketorolac tromethamine and sublingual tramadol hydrochloride used for pain.
MX391125B (en) PHARMACEUTICAL COMPOSITION OF LORATADINE, PHENYLEPHRINE, PARACETAMOL AND AMANTADINE FOR ORAL ADMINISTRATION, FOR THE TREATMENT OF ALLOPATHIES RELATED TO THE COMMON COLD.
MX2015009681A (en) A combination medicament comprising phenylephrine and paracetamol.
CL2017000026A1 (en) Pharmaceutical dosage forms
EA201692424A1 (en) COMBINATION OF LOXOPROPHENE AND AGONIST OF GAMMA-AMINOIL ACID RECEPTORS
MX2014005152A (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient.
MX2020004403A (en) Pharmaceutical compositions comprising safinamide.
TW201611830A (en) Pharmaceutical formulation for reducing bladder spasms and method of use thereof
MX2015007749A (en) Pharmaceutical composition of amanthadine hydrochloride-loratadin e-paracetamol in a capsule for treating colds amongst other allopathy.